Brief: Phasebio Pharmaceuticals Announces Bentracimab Manufacturing Update
08/03/2022 13:17
March 8 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO PHARMACEUTICALS ANNOUNCES BENTRACIMAB MANUFACTURING UPDATE
* PHASEBIO - MANUFACTURING OF BENTRACIMAB DRUG SUBSTANCE AND DRUG PRODUCT
PROCESS
PERFORMANCE QUALIFICATION (PPQ) BATCHES HAS BEEN COMPLETED
* PHASEBIO PHARMACEUTICALS INC - PHASEBIO REMAINS ON TRACK TO SUBMIT
BENTRACIMAB
BIOLOGICS LICENSE APPLICATION (BLA) IN MID-2022
Source text for Eikon: ID:nBw7f8cXDa
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans